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Literature Review
• Widely used as a cancer model
• Development of the embryo is ex-utero and transparent 
• Observation of cancer progression in a live model without harming or killing the embryo
• Zebrafish not adversely affected by genetic knockouts and expression of transgenes
• Better than other models because they are cheaper and can be studied within a five day post injection period
• Can also be injected with fluorescent dyes to see progression in vivo
Using ITGA6 Manipulations in Drug Screening
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Angiogenesis, Metastasis and Cancer Stem Cells 
Angiogenesis: the formation of 
blood vessels that grow from the 
tumor into the blood stream. 
These blood vessels allow cancer 
cells to migrate to other organs.
Metastasis: the dissemination of 
cancer cells throughout the body 
via blood vessels created during 
angiogenesis, accounting for 
approximately 90% of all deaths.
Cancer Stem Cells:  cancer cells 
are self renewing  cells that co-
exist within normal cancer cell 
populations and give rise to 
secondary tumors. 
Integrin Alpha 6 (ITGA6) in Tumor Development
• Integrins are transmembrane proteins 
that aid in extracellular and intracellular 
communication.
• ITGA6 has been found in several cancers 
including nueroblastomas, prostate 
cancer, and breast cancer.
• ITGA6 gene expression has been found 
at both upregulated and downregulated 
gene expressions leading to increased 
susceptibility to tumor development.
• ITGA6 also has been shown to be a 
proangiogenic factor, as well as, a factor 
that affects metastasis. 
• A new strategy that can detect the 
presence of cancer and prevent the 
disease are the current goals of the 
experiments. 
Manipulation of Human ITGA6 in Zebrafish Cells
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The image above shows Human 
Mutated ITGA6 RNA. In this 
construct, the ITGA6 is mutated in 
the cleavable part of ITGA6 
resulting in a non-cleavable ITGA6. 
Zebrafish embryos are injected with 
their respective RNA at 0hpf.
Human ITGA6 Full Length RNA Human ITGA6 Truncated RNA Human ITGA6 Mutated RNA 
The above images show ITGA6 in vivo in Zebrafish cells at 8hpf. ITGA6 was fluorescently tagged using 
immunohistochemistry and imaged using a laser confocal microscope. Image 4 (left) displays Human Full Length 
ITGA6 RNA. Image 5 (middle) displays cells injected with Human Truncated ITGA6, and image 6 (right) shows 
cells with Human Mutated ITGA6 RNA. 
Both images display PC3
cells. The image shows
labeled PC3 cells with DiI
(red) that allow for clear
visibility of the cells in the
embryo. DiI labeled cells
are injected into the
embryo at 24hpf.
The image on the left shows
metastasis in the trunk of the
body. The image on the right
shows no metastases in the
zebrafish (control).
• Cancer is defined as a disease
characterized by abnormal growth
of cells due to uncontrollable cell
division.
• 14 million people are diagnosed 
annually and  of those 8 million 
will die, making cancer the most 
deadly disease.
• Prostate cancer is prevalent in
males with over three million
people living with this cancer
today and a death rate of 13%.
• Biomarkers can be used a
diagnostic tool to identify possible
cancers in the body before their
growth.
Labeling of Human PC3 Cancer Cells
• Continue Human ITGA6 manipulation at the 
host level
• Investigate the effects of manipulating 
ITGA6 expression in Human PC3 cancer 
cells, on tumor progression.
• Use the favorable zebrafish tumor xenograft 
model to conduct a drug screening. 
The image on the left displays a potential 
experiment to assay the effects of anticancer 
drugs on Zebrafish and would be used as a 
preliminary tool to begin drug screening.
Human Full Length ITGA6 Human Truncated ITGA6 Human Mutated ITGA6
The graph to the left
displays the number of
embryos exhibiting
metastasis (%) for each
ITGA6 construct. A
significant p-value of less
than 0.01 using a t-test
was found in the full
length and truncated
constructs. This data
suggests that both
increasing and cleaving
ITGA6 lead to increased
tumor progression.
The image above shows a 
model of the Human Full 
Length ITGA6 RNA construct or 
genetic manipulation, in which 
fish cells have an increased 
amount of ITGA6 on the cell 
surface.
The image above shows 
Human Truncated ITGA6 
RNA, in which the ITGA6 in 
truncated or cleaved from 
the cell, resulting in 
increased amounts of ITGA6 
in the tumor tissue.
To create the Human PC3 Zebrafish Tumor Xenografts, 
Human ITGA6 RNA is injected into zebrafish embryos (0 
hpf). Human PC3 cells are cultured and labeled with DiI
cell labeling solution before being injected into the yolk 
region of zebrafish embryos (24 hpf).  Zebrafish embryos 
are observed daily for metastasis and angiogenesis using 
the Zeiss AX10 light microscope. Results are then analyzed 
using immunohistochemistry and laser confocal imaging. 
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Figure 2. Tumor Angiogenesis 
and Tumor Metastasis
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